BeStock  

Opko Health OPK

US equityMarket cap rank #3217Diagnostics & Research
$1.39 −$0.07 (-4.79%)
Pre-market · Oct 8, 9:10 am ET · After hours $1.39 -0.02%
Open$1.42
Prev close$1.46
Day range$1.38 – $1.43
Volume2.22M
Market cap$1.04B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$163.58M+4.3% YoY
Operating profit-$25.04M+58.3% YoY
Net profit-$8.42M+94.3% YoY
Diluted EPS-$0.01+94.7% YoY
Free cash flow-$46.50M+46.4% YoY
Operating cash flow-$43.50M

Revenue, last 8 quarters

$173.6MSep '24$183.6MDec '24$150.0MMar '25$156.8MJun '25$151.7MSep '25$148.5MDec '25$124.2MMar '26$163.6MJun '26

Net profit, last 8 quarters

$24.9MSep '24$14.0MDec '24$-67.6MMar '25$-148.4MJun '25$21.6MSep '25$-31.3MDec '25$-54.8MMar '26$-8.4MJun '26

Diluted EPS by quarter

0.03Sep '240.01Dec '24-0.10Mar '25-0.19Jun '250.03Sep '25-0.04Dec '25-0.07Mar '26-0.01Jun '26

Free cash flow by quarter

$-85.0MSep '24$-49.8MDec '24$-37.7MMar '25$-86.7MJun '25$-37.8MSep '25$-28.6MDec '25$-21.1MMar '26$-46.5MJun '26

Annual revenue

$1.4BFY20$1.8BFY21$1.0BFY22$863.5MFY23$713.1MFY24$606.9MFY25

Profitability & balance sheet

Gross margin40.8%
Operating margin-28.6%
Net margin-12.4%
Return on equity-5.9%
Return on assets-3.8%
Return on invested capital-2.7%
Current ratio3.35
Liabilities / assets35.3%
Cash & investments$300.76M
Total debt$385.69M
Net cash (debt)-$84.93M

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Pharmaceutical$89.03M 54.4%
  • Diagnostics$74.55M 45.6%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $163.58M $124.20M $606.88M $148.45M $151.67M
Total Operating Revenue $163.58M $124.20M $606.88M $148.45M $151.67M
Cost of Revenue $83.56M $78.44M $400.94M $84.43M $101.78M
Gross Profit $80.02M $45.76M $205.94M $64.03M $49.89M
Operating Expense $105.06M $96.77M $424.93M $102.34M $103.41M
Selling and Admin Expenses $52.92M $48.61M $223.00M $50.52M $53.80M
Research & Development $33.17M $29.20M $124.03M $32.77M $30.08M
Depreciation & Amortization & Depletion $18.97M $18.97M $77.89M $19.06M $19.53M
-Depreciation & Amortization $18.97M $18.97M $77.89M $19.06M $19.53M
Operating Profit -$25.04M -$51.02M -$218.99M -$38.32M -$53.52M
Net Non-Operating Interest Income (Expense) -$8.16M -$7.93M -$93.65M -$7.49M -$8.34M
Non-Operating Interest Income $3.22M $3.01M $14.81M $3.82M $3.02M
Non-Operating Interest Expense $11.38M $10.94M $108.46M $11.31M $11.36M
Other Income (Expense) $19.80M -$2.01M $71.27M -$1.09M $103.29M
Gain on Sale of Security -$65,000.00 -$298,000.00 -$429,000.00 -$134,000.00 -$38,000.00
Special Income (Charges) $18.07M – $101.58M $0.00 $101.58M
-Gain on Sale of Property/Plant/Equipment $18.07M – $101.58M $0.00 $101.58M
Other Non-Operating Income (Expenses) $1.80M -$1.71M -$29.88M -$960,000.00 $1.75M
Pretax Profit -$13.40M -$60.96M -$241.36M -$46.90M $41.43M
Tax -$4.98M -$6.11M -$15.71M -$15.66M $19.80M
Earnings from Equity Interest Net of Tax $0.00 -$2,000.00 -$29,000.00 -$17,000.00 -$3,000.00
Net Profit -$8.42M -$54.85M -$225.68M -$31.26M $21.63M
Profit from Continuing Operations -$8.42M -$54.85M -$225.68M -$31.26M $21.63M
Net Income to Parent Company -$8.42M -$54.85M -$225.68M -$31.26M $21.63M
Net Income to Common Stockholders -$8.42M -$54.85M -$225.68M -$31.26M $21.63M
Basic EPS -$0.01 -$0.07 -$0.30 -$0.04 $0.03
Diluted EPS -$0.01 -$0.07 -$0.30 -$0.04 $0.03
-Less:Restructuring and Mergern & Acquisition – – $0.00 – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $1.83B $1.86B $1.93B $1.93B $2.00B
Total Current Assets $500.24M $535.36M $581.88M $581.88M $627.13M
Cash and Cash Equivalents & Short-Term Investments $300.76M $341.88M $369.07M $369.07M $415.20M
-Cash and Cash Equivalents $300.76M $341.88M $369.07M $369.07M $415.20M
Receivables $114.91M $107.62M $126.12M $126.12M $124.38M
-Accounts Receivable $81.89M $79.64M $90.26M $90.26M $94.58M
-Taxes Receivable $7.84M $6.06M $11.84M $11.84M $7.44M
-Other Receivables $25.19M $21.93M $24.02M $24.02M $22.36M
Prepaid Assets $12.87M $11.71M $12.70M $12.70M $14.94M
Inventory $61.85M $64.40M $65.82M $65.82M $64.95M
Other Current Assets $9.84M $9.76M $8.17M $8.17M $7.66M
Total Non-Current Assets $1.33B $1.32B $1.35B $1.35B $1.37B
Net PPE $115.43M $118.39M $120.86M $120.86M $120.68M
-Gross PPE $115.43M $118.39M $246.47M $246.47M $120.68M
Investments and Advances $40.21M $10.53M $14.17M $14.17M $13.36M
-Available for Sale Securities $39.46M $9.77M $13.41M $13.41M $12.59M
-Long Term Equity Investment $755,000.00 $756,000.00 $758,000.00 $758,000.00 $775,000.00
Financial Assets $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
Goodwill and Other Intangible Assets $1.15B $1.17B $1.20B $1.20B $1.21B
-Goodwill $481.52M $482.27M $484.29M $484.29M $484.03M
-Other Intangible Assets $672.57M $691.35M $711.28M $711.28M $730.38M
Other Non-Current Assets $19.49M $18.90M $19.47M $19.47M $19.93M
Total Liabilities $645.29M $652.19M $663.99M $663.99M $690.02M
Total Current Liabilities $149.37M $148.38M $146.68M $146.68M $169.32M
Payables $56.47M $48.81M $44.70M $44.70M $61.28M
-Accounts Payable $50.04M $44.18M $41.10M $41.10M $50.83M
-Total Tax Payable $6.43M $4.63M $3.60M $3.60M $10.45M
Current Accrued Expenses $35.55M $36.30M $39.45M $39.45M $39.47M
Short-Term Debt and Capital Lease Obligation $22.96M $22.26M $22.86M $22.86M $24.35M
-Current Debt $10.56M $9.65M $10.25M $10.25M $12.79M
-Current Capital Lease Obligation $12.40M $12.61M $12.61M $12.61M $11.56M
Current Provisions $5.43M $5.79M $5.90M $5.90M $5.55M
Total Non-Current Liabilities $495.92M $503.80M $517.31M $517.31M $520.70M
Long Term Debt and Capital Lease Obligation $375.13M $374.67M $373.92M $373.92M $371.07M
-Long Term Debt $338.49M $336.03M $333.72M $333.72M $331.43M
-Long Term Capital Lease Obligation $36.64M $38.64M $40.21M $40.21M $39.64M
Non-Current Deferred Liabilities $108.23M $114.56M $126.24M $126.24M $130.34M
Employee Benefits $1.18M $3.19M $5.54M $5.54M $7.55M
Other Non-Current Liabilities $11.39M $11.38M $11.60M $11.60M $11.73M
Total Equity $1.18B $1.20B $1.27B $1.27B $1.31B
Stockholders' Equity $1.18B $1.20B $1.27B $1.27B $1.31B
Capital Stock $7.76M $7.85M $7.90M $7.90M $7.99M
-Common Stock $7.76M $7.85M $7.90M $7.90M $7.99M
Additional Paid-In Capital $3.56B $3.57B $3.57B $3.57B $3.58B
Retained Earnings -$2.35B -$2.35B -$2.29B -$2.29B -$2.26B
Less: Treasury Stock $2.36M $1.79M $3.18M $3.18M $2.39M
Gains/Losses Not Affecting Retained Earnings -$28.39M -$27.49M -$21.02M -$21.02M -$25.47M
-Accumulated Depreciation – – -$125.62M -$125.62M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$43.50M -$19.31M -$178.54M -$25.92M -$34.65M
Net cash flow from continuing operations -$43.50M -$19.31M -$178.54M -$25.92M -$34.65M
Net Income from Continuing Operations -$8.42M -$54.85M -$225.68M -$31.26M $21.63M
Gain/Loss from Continuing Operations -$45.19M -$32,000.00 -$72.15M -$829,000.00 -$67.47M
Depreciation & Depletion & Amortization $22.41M $22.20M $91.63M $22.37M $22.74M
Deferred Tax -$6.27M -$7.89M -$15.00M -$10.15M $18.29M
Other Non-Cash Items $2.69M $2.57M $71.49M $2.53M -$30.20M
Change in Working Capital -$8.61M $12.02M -$41.18M -$12.13M -$1.88M
-Change in Receivables -$2.39M $9.53M $30.21M $6.71M $4.39M
-Change in Inventory $2.84M $191,000.00 -$4.12M $1.17M $624,000.00
-Change in Payables and Accrued Expense -$2.94M -$4.67M -$62.06M -$20.84M -$5.66M
-Change in Other Current Assets -$6.26M $6.84M -$5.40M -$4.02M $1.45M
-Change In Other Working Capital $136,000.00 $126,000.00 $178,000.00 $4.84M -$2.68M
Net cash flow from investing $15.54M -$1.80M $230.30M -$2.05M $194.65M
Net Cash Flow from Continuing Investing Activities $15.54M -$1.80M $230.30M -$2.05M $194.65M
Capital Expenditure -$3.00M -$1.83M -$12.28M -$2.67M -$3.14M
Net PPE Purchase and Sale $148,000.00 $33,000.00 $287,000.00 $93,000.00 $13,000.00
Net Business Purchase and Sale $18.39M $0.00 $190.11M $0.00 $197.77M
Net Investment Purchase and Sale $0.00 $0.00 $52.18M $527,000.00 $0.00
Financing Cash Flow -$13.03M -$5.16M -$118.06M -$18.34M -$16.21M
Net Cash Flow from Continuing Financing Activities -$13.03M -$5.16M -$118.06M -$18.34M -$16.21M
Net Issuance Payments Of Debt $333,000.00 -$390,000.00 -$70.76M -$4.70M -$928,000.00
Net Common Stock Issuance -$13.02M -$4.77M -$47.04M -$13.51M -$15.28M
Proceeds from Stock Option Exercised -$339,000.00 $0.00 -$256,000.00 -$133,000.00 $0.00
Ending Cash Balance $314.43M $355.57M $382.74M $382.74M $428.87M
Net Change in Cash -$40.99M -$26.27M -$66.30M -$46.31M $143.80M
Beginning Cash Balance $355.57M $382.74M $445.62M $428.87M $285.40M
Effect of Exchange Rate Changes -$145,000.00 -$908,000.00 $3.43M $174,000.00 -$316,000.00
Free Cash Flow -$46.50M -$21.14M -$190.82M -$28.59M -$37.78M

Discussion

No comments yet — be the first to weigh in on OPK.

Leave a comment

Scroll to Top